Morgan Stanley »

Aerovate Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $777k 26k 29.57
2023-09-30 $259k 19k 13.57
2023-06-30 $566k 33k 17.15
2022-12-31 $65k 2.2k 29.50
2022-06-30 $0 7.9k 0.00
2022-03-31 $136k 7.6k 17.99